Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Price/Access Standoff: Can Anyone Be Happy?

This article was originally published in Scrip

Executive Summary

Before stakeholders even gathered at a forum being convened on Nov. 20 at the Health and Human Services (HHS) headquarters near Capitol Hill in Washington to thrash out how best to ensure patients have access to affordable medicines while making sure industry can recoup its costs and reinvest in research and development, various groups already had drawn their battle lines.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC063754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel